Xtant Medical Holdings (XTNT) Accumulated Depreciation & Amortization (2011 - 2025)

Xtant Medical Holdings (XTNT) has 15 years of Accumulated Depreciation & Amortization data on file, last reported at $5.2 million in Q4 2025.

• Accumulated Depreciation & Amortization for Q4 2025 came in at $5.2 million, up 23.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.2 million (up 23.65% YoY), and the FY2025 annual result was $5.2 million, up 23.65% from the prior year.
• Accumulated Depreciation & Amortization slipped to $5.2 million in Q4 2025 per XTNT's latest filing, from $21.9 million in the prior quarter.
• Over five years, Accumulated Depreciation & Amortization peaked at $21.9 million in Q3 2025 and troughed at $4.2 million in Q4 2024.
• A 5-year average of $17.5 million and a median of $18.1 million in 2022 frame the typical range for Accumulated Depreciation & Amortization.
• The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation & Amortization slumped 78.54% in 2024, then rose 23.65% in 2025.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $17.2 million in 2021, then climbed by 4.63% to $18.0 million in 2022, then climbed by 9.55% to $19.7 million in 2023, then tumbled by 78.54% to $4.2 million in 2024, then increased by 23.65% to $5.2 million in 2025.
• Business Quant data shows XTNT's Accumulated Depreciation & Amortization at $5.2 million in Q4 2025, $21.9 million in Q3 2025, and $21.2 million in Q2 2025.